We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

FAPON

Fapon is a global IVD raw materials & one-stop solutions company offering 700+ reagent raw materials for the applicat... read more Featured Products: More products

Download Mobile App





Fapon Presents Comprehensive Range of One-Stop IVD Solutions

By LabMedica International staff writers
Posted on 04 Feb 2025

Fapon Biotech (Dongguan, China) is showcasing its comprehensive one-stop IVD solutions and sharing the latest industry insights with its global partners at Medlab Middle East 2025. More...

Leveraging its cutting-edge technologies and vast industry experience, Fapon has introduced its technology transfer and local manufacturing services to best underscore its commitment to enhancing local IVD industry development.

At the exhibition, Fapon is presenting a range of IVD solutions covering a wide spectrum of technology applications, including chemiluminescence immunoassay (CLIA), biochemistry, next-generation sequencing (NGS), polymerase chain reaction (PCR), lateral flow assay (LFA), and fluorescence immunoassay (FIA) for both clinical diagnostic laboratories and point-of-care testing (POCT) scenarios. Leveraging its strong foundation in IVD technologies, Fapon integrates open-system instruments, reagent services, and raw materials into One-stop IVD solutions. This approach ensures reliable, versatile, and seamless services for its IVD partners, especially local IVD companies and distributors that are establishing or expanding their own IVD production lines. Ultimately, these efforts benefit local hospitals and patients. Fapon's goal is to elevate the product portfolios of global IVD manufacturers and reduce their time-to-market through technology transfer and local manufacturing.

Fapon's CLIA and biochemistry product lines exemplify its expertise in One-stop IVD solutions. Its CLIA One-stop solution includes the Shine i-series open-system CLIA analyzers for low- to ultra-high-throughput testing, alongside over 80 reagent services for assays such as vitamin D, NT-proBNP, hs-cTnI, and PCT, and core IVD raw materials. Fapon is able to provide one-stop CLIA products and services from development, evaluation/registration, and QMS construction to after-sales. In addition, Fapon's biochemistry One-stop solution offers matching antibodies, antigens, latex particles, coupling procedures, and biochemistry analyzers, enabling its partners to successfully develop their IVD tests in a short time. Collectively, they demonstrate Fapon's commitment to advancing diagnostic technologies and customization services to meet the localization needs of the IVD manufacturers. Fapon's PCR one-stop solution can provide POCT instruments that can provide results in as fast as 30 minutes, along with customized reagent services. Fapon's FIA one-stop solution can offer multiple analyzers and reagents for over 40 types of diseases.


Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Serological Pipet Controller
PIPETBOY GENIUS
New
Silver Member
Cell and Tissue Culture Plastics
Diamond® SureGro™ Cell and Tissue Culture Plastics
New
Respiratory Syncytial Virus Test
OSOM® RSV Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Non-coding RNAs CBR3-AS1 and PCA3 can be utilized as therapeutic targets and prognostic biomarkers in gastric cancer (Photo courtesy of Adobe Stock)

Promising Molecular Markers Support Earlier Diagnosis of Gastric Cancer

Late detection continues to make gastric cancer one of the leading causes of cancer-related deaths globally. With improved early detection tools urgently needed, researchers have now identified two long... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The tip optofluidic immunoassay platform enables rapid, multiplexed antibody profiling using only 1 μL of fingertip blood (Photo courtesy of hLife, DOI:10.1016/j.hlife.2025.04.005)

POC Diagnostic Platform Performs Immune Analysis Using One Drop of Fingertip Blood

As new COVID-19 variants continue to emerge and individuals accumulate complex histories of vaccination and infection, there is an urgent need for diagnostic tools that can quickly and accurately assess... Read more

Pathology

view channel
Image: The new technology combines a rapid hemoglobin test with a smartphone app (Photo courtesy of 123RF)

Smartphone-Based Rapid Hemoglobin Test Accurately Detects Colorectal Cancer

Despite the availability of colorectal cancer screening programs, participation remains low, especially for fecal immunochemical tests (FIT), a non-invasive method to detect hidden blood in the stool.... Read more

Technology

view channel
Image: The machine learning-based method delivers near-perfect survival estimates for PAC patients (Photo courtesy of Shutterstock)

AI Method Predicts Overall Survival Rate of Prostate Cancer Patients

Prostate adenocarcinoma (PAC) accounts for 99% of prostate cancer diagnoses and is the second most common cancer in men globally after skin cancer. With more than 3.3 million men in the United States diagnosed... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.